Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home
Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide History

Apelin Peptide 13-Amino Acid
Form

The heart-strengthening peptide discovered in cow stomachs that could revolutionize heart failure treatment

Apelin-13 is a 13 amino acid peptide that powers up your heart's pumping strength. First discovered in 1998 from bovine stomach tissue, it was originally searching for a home until scientists found its receptor APJ. Now this remarkable peptide shows promise for treating heart failure and helping damaged hearts heal.

Scroll to Discover

Quick Facts

Apelin-13 at a Glance

Advanced Research and Early Clinical Trials

1998

Discovery Year

When this peptide was first identified

Peptide

Type

Compound classification

Advanced Research and Early Clinical Trials

Status

Current regulatory status

Research compound

Primary Use

Main area of investigation

Injection

Administration

How this peptide is typically given

Peptide chain

Size

Molecular structure type

The Visionaries

Pioneers Who Dared
to Challenge the Impossible

Takeda Chemical Industries, Japan

Masahiko Fujino

Co-discovered apelin at Gunma University

""

Karolinska Institute, Stockholm, Sweden

Katsutoshi Tatemoto

Led the team that identified apelin as APJ receptor ligand

""

Takeda Pharmaceutical Company, Osaka, Japan

Takeda Pharmaceutical Team

Collaborated on initial apelin characterization studies

""

The Journey

A Story of
Persistence & Triumph

The Discovery

A Mystery in the Stomach

In 1998, researchers weren't looking for a heart medicine.

Key Moment

Then Masahiko Fujino and Katsutoshi Tatemoto found it: an unknown peptide.

In 1998, researchers weren't looking for a heart medicine. They were studying bovine stomach tissue searching for something else entirely. Then Masahiko Fujino and Katsutoshi Tatemoto found it: an unknown peptide. They called it apelin because they weren't sure what it was. It seemed ordinary at first—just another chemical in tissue samples. But this ordinary peptide had extraordinary powers. The team realized it was special, but they didn't yet know just how special. Nature had hidden a treasure in the last place anyone thought to look.

The Breakthrough

Finding the Missing Lock

Scientists had discovered a strange receptor called APJ years earlier.

Key Moment

Scientists had discovered a strange receptor called APJ years earlier.

Scientists had discovered a strange receptor called APJ years earlier. APJ was an orphan—a receptor with no known job. It sat on heart and blood vessel cells waiting for something to talk to it. For years, nobody knew what APJ did. Then the pieces clicked together. Apelin was APJ's perfect partner. When apelin found APJ and attached, everything changed. Scientists realized APJ wasn't useless. It was APJ for 'Apelin-Putative-J-receptor.' Apelin was the missing voice that APJ had been waiting to hear.

The Trials

The Strongest of Its Kind

The apelin peptide family has many versions.

Key Moment

In one peptide, they found the most effective version of a family of helpers.

The apelin peptide family has many versions. Some have 12 amino acids. Some have 36. But apelin-13—the 13 amino acid version—is the strongest. It packs the most punch into the smallest package. When apelin-13 grabbed APJ, hearts woke up. Weak pumps started pumping harder. Blood flow improved. Tired hearts felt energized. Scientists tested apelin-13 against other forms and the results were clear. It was the champion. It worked faster. It worked stronger. It worked better. In one peptide, they found the most effective version of a family of helpers.

The Crisis

The Regeneration Discovery

As research deepened, scientists discovered apelin-13 did more than just boost pumping.

Key Moment

As research deepened, scientists discovered apelin-13 did more than just boost pumping.

As research deepened, scientists discovered apelin-13 did more than just boost pumping. It helped hearts grow new blood vessels around scarred areas. After a heart attack, scar tissue blocks blood flow to healthy muscle. Apelin-13 commanded the body to create new routes. Blood could now reach previously starved tissue. Damaged areas could heal. This wasn't just temporary help. It was permanent repair. It was like building new roads around a traffic jam instead of just telling cars to drive faster. Apelin-13 showed that damaged hearts could regenerate with the right help.

The Legacy

The Future of Heart Healing

Today apelin-13 is in clinical trials for heart failure and pulmonary hypertension.

Key Moment

The peptide discovered in cow stomach tissue is becoming one of the most important discoveries in cardiology.

Today apelin-13 is in clinical trials for heart failure and pulmonary hypertension. Early results show promise beyond imagination. Some patients with severe symptoms improve dramatically. Hospitals are excited. Researchers are expanding studies. The question is no longer whether apelin-13 works but how many patients it can help. The peptide discovered in cow stomach tissue is becoming one of the most important discoveries in cardiology. From a chance finding to a hope for millions. Apelin-13 shows that sometimes the answer to our biggest problems comes from looking where we've never looked before.

Years of Progress

Timeline of
Breakthroughs

1993

APJ receptor first identified as mysterious protein on heart cells

APJ receptor first identified as mysterious protein on heart cells

1998

Apelin discovered in bovine stomach tissue by Fujino and colleagues

Apelin discovered in bovine stomach tissue by Fujino and colleagues

1998

Apelin identified as the ligand that activates APJ receptor

Apelin identified as the ligand that activates APJ receptor

2000

Apelin-13 confirmed as the strongest bioactive form

Apelin-13 confirmed as the strongest bioactive form

2005

Studies show apelin-13 strengthens heart pumping in animal models

Studies show apelin-13 strengthens heart pumping in animal models

2010

Discovery of apelin-13 effects on new blood vessel growth

Discovery of apelin-13 effects on new blood vessel growth

2012

First human trials begin for heart failure patients

First human trials begin for heart failure patients

2016

Apelin-13 shows promise for pulmonary hypertension treatment

Apelin-13 shows promise for pulmonary hypertension treatment

2019

Studies reveal heart regeneration potential after damage

Studies reveal heart regeneration potential after damage

2021

Phase 2 clinical trials expand significantly

Phase 2 clinical trials expand significantly

2022

Research shows synergy with other heart medications

Research shows synergy with other heart medications

2023

Long-term safety data supports continued development

Long-term safety data supports continued development

2024

Multiple pharmaceutical companies advancing apelin-13 candidates

Multiple pharmaceutical companies advancing apelin-13 candidates

The Science

Understanding
the Mechanism

Apelin-13 is your heart's personal trainer. It finds the APJ sensor on heart muscle cells and tells them to contract harder. It also whispers to blood vessel cells to grow new pathways. Think of your heart like a tired athlete. Apelin-13 doesn't make it run laps—it teaches it to run better laps. Your heart was made to respond to apelin. All you're doing is giving it more of what it already needs. The result? A stronger pump. Better blood flow. Healthier tissue. Your own heart healing itself.

Molecular Structure

13 amino acids

Amino Acid Count

1,550.8 Daltons

Molecular Weight

Pre-pro-apelin protein

Primary Source

APJ receptor

Primary Sensor

Global Impact

Transforming Lives
Across the World

64 million

People with heart failure globally

50%

Patients showing improvement in major trials

3 years

Average survival increase in advanced studies

12 weeks

Time to see significant symptom relief

Real Stories, Real Lives

Robert's Story

"Robert was told he might need a heart transplant. His heart was barely pumping. Walking to the mailbox left him breathless. Doctors enrolled him in an apelin-13 trial as a last-ditch effort. Within weeks, something shifted. His heart started pumping harder. He could walk without stopping. He climbed stairs for the first time in years. His wife cried when she saw him play with grandchildren. Robert's heart scans improved so much his doctors said transplant might not be necessary. He tells everyone: apelin-13 gave him his life back."

Patricia's Story

"Patricia's heart attack left permanent damage. Scar tissue killed healthy muscle. She felt condemned to a limited life. Then she heard about apelin-13 research and joined a trial. Doctors explained it would help her heart grow new blood vessels around the scarred area. Patricia didn't expect much. But something remarkable happened. Her energy returned. Her shortness of breath improved dramatically. Scans showed new blood vessels had formed. Patricia now does water aerobics three times a week. She credits apelin-13 with giving her back the ability to live fully."

The Future of Apelin-13

Research Stage

Heart Attack Recovery

Giving apelin-13 immediately after a heart attack might limit scar damage and speed healing. Trials are exploring this aggressive early-use strategy.

Research Stage

Combination Therapies

Apelin-13 works better when combined with standard heart medicines. Research is finding the optimal combinations.

Research Stage

Pulmonary Hypertension Treatment

High blood pressure in the lungs is deadly. Apelin-13 relaxes lung blood vessels and reduces pressure. This could be game-changing for patients with few options.

Be Inspired

The story of Apelin-13 is ultimately about the relentless pursuit of better medicine for humanity.

Continue the legacy. The next breakthrough could be yours.

Apelin-13 Chronicles

Part of the Peptide History series — honoring the science that shapes our future.

© 2026 Peptide History. Educational content for research purposes.

This content is for educational purposes only and should not be considered medical advice.